SCHEMBL5366127

SCHEMBL5366127

CNc1nc(-c2ccccc2)n(-c2ccccc2)c1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 1/20 0.42
IKBKB O14920 1/20 0.40
CHUK O15111 1/20 0.40
CDK2 P24941 1/20 0.40
PLK1 P53350 1/20 0.40
BTK Q06187 1/20 0.40
ITK Q08881 1/20 0.40
IKBKE Q14164 1/20 0.40
HCAR1 Q9BXC0 1/20 0.39
PI4KA P42356 1/20 0.39
PI4K2B Q8TCG2 1/20 0.39
PI4K2A Q9BTU6 1/20 0.39
PI4KB Q9UBF8 1/20 0.39
MAT2A P31153 2/20 0.39
MDM2 Q00987 1/20 0.39
TSHR P16473 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
GLA P06280 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5366008 0.83 MAPK1 (0.46) AVPR1AHCAR1PI4KAPI4K2BPI4K2A
SCHEMBL5374571 0.80 IKBKB (0.48) IKBKBCHUKCDK2PLK1BTK
SCHEMBL5366123 0.79 AVPR1A (0.44) AVPR1AHCAR1PI4KAPI4K2BPI4K2A
SCHEMBL5374635 0.78 TSHR (0.47) TSHRGLAALDH1A1HPGDSMN1; SMN2
SCHEMBL5367545 0.75 PI4KA (0.53) AVPR1AHCAR1PI4KAPI4K2BPI4K2A
SCHEMBL5378320 0.74 MAT2A (0.46) AVPR1AHCAR1PI4KAPI4K2BPI4K2A
SCHEMBL5376001 0.73 DHODH (0.43) IKBKBCHUKCDK2PLK1BTK
Hydrochloric Acid SCHEMBL1895670 0.72 IKBKB (0.47) IKBKBCHUKCDK2PLK1BTK
SCHEMBL5378318 0.69 AVPR1A (0.44) AVPR1AHCAR1PI4KAPI4K2BPI4K2A
SCHEMBL5365961 0.69 KDM4E (0.44) MAT2ATSHRMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7238212-B2 Imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2007-07-03 US claimed
US-20050011019-A1 Novel imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2005-01-20 US claimed
EP-1484049-A1 Imidazole compounds and their use for dyeing of keratinous fibres L'OREAL (FR) 2004-12-08 EP claimed
US-7238212-B2 Imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2007-07-03 US disclosed
US-20050011019-A1 Novel imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2005-01-20 US disclosed
EP-1484049-A1 Imidazole compounds and their use for dyeing of keratinous fibres L'OREAL (FR) 2004-12-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050011019-A1 Novel imidazole compounds and use of these compounds for dyeing keratinous fibers KRT18, VIM, NDUFS6 AVPR1A 4360/4885IKBKB 1683/4885CHUK 1705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.